Exam (elaborations)
CSP NASP QUESTION BANK PLUS CSP HANDBOOK QUESTIONS
- Module
- Institution
RB is a 20 year old female recently approved for CF treatment with Trikafta® (elexacaftor/tezacaftor/ivacaftor). She is homozygous for the F508 del mutation in the CFTR gene and meets criteria for treatment with this medication. Her current medications include inhaled albuterol, normal saline, tob...
[Show more]